CIK: 0001587114 · Show all filings
Period: Q4 2025 (← Previous)
Filing Date: Feb 17, 2026
Total Value ($000): $2,204,009 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| CGON | CG ONCOLOGY INC | 772,000 | $32,053 | 1.5% | $41.38 | 0.0% | COM | 156944100 |
| ZBIO | ZENAS BIOPHARMA INC | 789,500 | $28,667 | 1.3% | $32.89 | 0.0% | COM | 98937L105 |
| GPCR | STRUCTURE THERAPEUTICS INC | 334,380 | $23,256 | 1.1% | $69.55 | — | SPONSORED ADS | 86366E106 |
| PCVX | VAXCYTE INC | 450,000 | $20,763 | 0.9% | $44.73 | 0.0% | COM | 92243G108 |
| CGON | CG ONCOLOGY INC | 292,800 | $12,157 | 0.6% | $41.38 | 0.0% | CALL | 156944100 |
| MNKD | MANNKIND CORP | 1,660,000 | $9,412 | 0.4% | $5.51 | 0.0% | COM NEW | 56400P706 |
| EOLS | EVOLUS INC | 675,000 | $4,489 | 0.2% | $6.77 | 0.0% | COM | 30052C107 |
| IBIO | IBIO INC | 2,228,000 | $4,300 | 0.2% | $1.36 | 0.0% | COM NEW | 451033708 |
| MREO | MEREO BIOPHARMA GROUP PLC | 7,856,466 | $3,274 | 0.1% | $0.42 | — | SPON ADS | 589492107 |
| CAMP | CAMP4 THERAPEUTICS CORP | 325,000 | $1,992 | 0.1% | $4.25 | 0.0% | COM | 13463J101 |
| XNCR | XENCOR INC | 67,500 | $1,033 | 0.0% | $32.11 | -53.5% | CALL | 98401F105 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| CNTA | CENTESSA PHARMACEUTICALS PLC | 3,115,000 (+466.4%) | $77,906 (+484.1%) | 3.5% | $24.88 | — | SPONSORED ADS | 152309100 |
| VYGR | VOYAGER THERAPEUTICS INC | 4,002,847 (+497.2%) | $15,731 (+402.5%) | 0.7% | $3.88 | — | COM | 92915B106 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| QURE | UNIQURE NV | 3,988,971 | $232,836 | 10.6% | $9.43 | +309.3% | — | N90064101 |
| TNGX | TANGO THERAPEUTICS INC | 10,630,736 | $89,298 | 4.1% | $7.06 | +22.1% | — | 87583X109 |
| APLS | APELLIS PHARMACEUTICALS INC | 3,447,156 | $78,009 | 3.5% | $43.04 | -45.5% | — | 03753U106 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 75,000 | $34,400 | 1.6% | $235.62 | +116.8% | — | 558868105 |
| RNA | AVIDITY BIOSCIENCES INC | 765,000 | $33,331 | 1.5% | $24.25 | +166.4% | — | 05370A108 |
| ALKS | ALKERMES PLC | 500,000 | $15,000 | 0.7% | $29.76 | +0.6% | — | G01767105 |
| — | METSERA INC | 271,529 | $14,209 | 0.6% | $28.22 | — | — | 59267L107 |
| PRME | PRIME MEDICINE INC | 1,543,326 | $8,550 | 0.4% | $4.06 | +9.5% | — | 74168J101 |
| KURA | KURA ONCOLOGY INC | 872,500 | $7,722 | 0.4% | $14.07 | -25.4% | — | 50127T109 |
| PEPG | PEPGEN INC | 800,000 | $3,696 | 0.2% | $1.61 | +222.0% | — | 713317105 |
| CMPS | COMPASS PATHWAYS PLC | 265,137 | $1,519 | 0.1% | $5.73 | — | — | 20451W101 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| XNCR | XENCOR INC | 3,251,112 (-47.1%) | $49,775 (-30.9%) | 2.3% | $32.11 | -53.5% | COM | 98401F105 |
| IMNM | IMMUNOME INC | 2,855,590 (-30.0%) | $61,338 (+28.4%) | 2.8% | $8.38 | +109.5% | COM | 45257U108 |
| SRZNW | SURROZEN INC | 4,444 (-93.3%) | $100 (-88.3%) | 0.0% | $7.07 | — | *W EXP 08/01/203 | 86889P117 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ZYME | ZYMEWORKS INC | 22,970,388 | $604,810 | 27.4% | $9.83 | +121.8% | COM | 98985Y108 |
| ANAB | ANAPTYSBIO INC | 7,880,094 | $382,027 | 17.3% | $23.54 | +65.6% | COM | 032724106 |
| JAZZ | JAZZ PHARMACEUTICALS PLC | 1,706,469 | $290,100 | 13.2% | $120.72 | +27.0% | SHS USD | G50871105 |
| MBX | MBX BIOSCIENCES INC | 2,123,604 | $66,978 | 3.0% | $18.46 | +31.5% | COM | 55287L101 |
| ORIC | ORIC PHARMACEUTICALS INC | 6,728,116 | $55,036 | 2.5% | $15.26 | -24.6% | COM | 68622P109 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 4,288,120 | $199,612 | 9.1% | $32.41 | +37.4% | COM | 22663K107 |
| CRSP | CRISPR THERAPEUTICS AG | 1,389,276 | $72,854 | 3.3% | $71.59 | -16.3% | NAMEN AKT | H17182108 |
| ETON | ETON PHARMACEUTICALS INC | 2,030,544 | $34,336 | 1.6% | $9.01 | +95.2% | COM | 29772L108 |
| — | NUVATION BIO INC | 963,333 | $8,631 | 0.4% | $10.45 | — | *W EXP 02/10/202 | 67080N119 |
| NGNE | NEUROGENE INC | 1,271,342 | $26,190 | 1.2% | $14.32 | +73.8% | COM | 64135M105 |
| GLPG | GALAPAGOS NV | 1,667,119 | $54,515 | 2.5% | $32.49 | — | SPON ADR | 36315X101 |
| BBOT | BRIDGEBIO ONCOLOGY THERAPEUT | 2,823,126 | $35,346 | 1.6% | $11.58 | — | COM NEW | 107924102 |
| AQST | AQUESTIVE THERAPEUTICS INC | 2,625,000 | $16,958 | 0.8% | $4.32 | +44.1% | COM | 03843E104 |
| ATRA | ATARA BIOTHERAPEUTICS INC | 573,183 | $10,369 | 0.5% | $13.39 | +11.5% | COM NEW | 046513206 |